FDA Adverse Event Injury Summary report: N

TELIGEN

MDR report key: 2173136 · Received July 23, 2011

Report

Report Number
2124215-2011-10298
Event Type
Injury
Date Received
July 23, 2011
Date of Event
May 27, 2011
Report Date
September 23, 2011
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION RECEIVED NOTED THAT THIS PATIENT HAD A HEMATOMA. NO FURTHER ACTION WAS TAKEN AND THE SYSTEM REMAINS IMPLANTED.

Additional Manufacturer Narrative · 1

SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS PATIENT IMPLANTED WITH THIS DEVICE PRESENTED WITH A POST SURGICAL INFECTION. THE DEVICE POCKET WAS SWOLLEN AND ANTIBIOTICS WERE ADMINISTERED. THE PATIENT IS SCHEDULED FOR A FOLLOW UP. NO ADVERSE PATIENT EFFECTS WERE ASSOCIATED WITH THE ANTIBIOTICS GIVEN.

Description of Event or Problem · 1

--

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND F110

Patients

Seq Age Sex Outcome Treatment
1 0185| F110| 0181